通过专为投资者打造的一站式数据看板，全面查看 Allogene Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

576.40M

股息TTM

0.00

市盈率 TTM

-2.18

每股收益TTM

-0.77

营业收入

0.00

净利润

-257.59M

净资产收益率

-52.32%

总资产收益率

-38.45%

Allogene Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

44.24%-0.13

36.07%-0.18

39.66%-0.17

41.17%-0.19

33.36%-0.23

27.83%-0.28

44.17%-0.28

14.70%-0.32

35.30%-0.35

44.42%-0.38

22.55%-0.51

---0.37

---0.54

---0.69

---0.66

---1.67

----

营业收入

--4.64M

----

--0.00

-100.00%0.00

-26.67%22.00K

-55.32%21.00K

-55.10%22.00K

-74.42%22.00K

-50.82%30.00K

-99.94%47.00K

0.00%49.00K

95.45%86.00K

-99.84%61.00K

--75.65M

--49.00K

净利润

16.23%-42.68M

28.67%-42.61M

35.25%-38.81M

37.55%-41.40M

23.23%-50.94M

8.10%-59.73M

30.12%-59.94M

-6.43%-66.29M

16.25%-66.36M

34.98%-65.00M

9.56%-85.78M

25.09%-62.29M

-5.94%-79.23M

-25.19%-99.97M

-110387.21%-94.85M

-6.35%-83.15M

-5.43%-74.79M

-141.86%-79.85M

100.13%86.00K

-18.11%-78.19M

利润率

---919.76%

----

11.34%-295454.55%

-102.41%-408466.67%

---283122.73%

---360145.45%

---333226.67%

---201802.13%

---121318.88%

----

毛利率

--100.00%

----

0.00%100.00%

----

--100.00%

----

利润表

营业收入

--4.64M

----

--0.00

-100.00%0.00

-26.67%22.00K

-55.32%21.00K

-55.10%22.00K

-74.42%22.00K

-50.82%30.00K

-99.94%47.00K

0.00%49.00K

95.45%86.00K

-99.84%61.00K

--75.65M

--49.00K

营业利润

13.81%-46.92M

29.30%-46.09M

29.90%-42.40M

26.45%-44.90M

18.07%-54.44M

6.21%-65.19M

15.83%-60.49M

3.10%-61.05M

17.50%-66.44M

29.86%-69.50M

25.43%-71.86M

23.63%-63.00M

-5.15%-80.54M

-23.88%-99.09M

-5745.81%-96.37M

-6.20%-82.49M

-7.83%-76.59M

-140.93%-79.99M

102.46%1.71M

-14.15%-77.67M

净利润

16.23%-42.68M

28.67%-42.61M

35.25%-38.81M

37.55%-41.40M

23.23%-50.94M

8.10%-59.73M

30.12%-59.94M

-6.43%-66.29M

16.25%-66.36M

34.98%-65.00M

9.56%-85.78M

25.09%-62.29M

-5.94%-79.23M

-25.19%-99.97M

-110387.21%-94.85M

-6.35%-83.15M

-5.43%-74.79M

-141.86%-79.85M

100.13%86.00K

-18.11%-78.19M

资产负债表

流动资产

20.29%340.00M

-6.27%273.29M

-15.04%257.75M

-14.35%260.72M

-38.17%282.65M

-26.25%291.58M

-33.92%303.39M

-35.70%304.42M

-8.96%457.12M

-17.88%395.36M

-13.18%459.12M

-16.80%473.45M

-2.13%502.10M

2.50%481.46M

12.20%528.82M

13.17%569.06M

-14.80%513.03M

-34.40%469.74M

-44.23%471.32M

-41.12%502.86M

流动负债总额

0.16%31.73M

-5.64%28.33M

-8.47%32.51M

-2.27%31.83M

-15.09%31.68M

-2.82%30.02M

-4.20%35.52M

-13.46%32.57M

-31.83%37.30M

-48.15%30.89M

-30.99%37.08M

-22.99%37.64M

21.85%54.72M

61.58%59.59M

11.53%53.73M

-8.63%48.87M

-2.37%44.91M

-32.77%36.88M

-48.92%48.17M

6.70%53.49M

总资产

16.89%550.09M

-22.05%395.96M

-24.20%415.90M

-25.35%439.77M

-27.25%470.59M

-13.37%507.98M

-14.64%548.71M

-17.30%589.12M

-16.10%646.88M

-21.49%586.35M

-21.76%642.84M

-19.74%712.33M

-18.64%770.97M

-22.57%746.87M

-20.90%821.58M

-17.76%887.57M

-15.89%947.64M

-18.19%964.63M

-15.41%1.04B

-11.72%1.08B

总负债

-9.61%113.92M

-4.49%117.08M

-2.50%123.36M

-0.74%124.44M

-4.41%126.03M

-1.92%122.59M

-3.12%126.53M

-2.98%125.37M

-10.95%131.84M

-19.16%124.98M

-15.57%130.60M

-12.46%129.22M

1.63%148.06M

41.32%154.61M

26.56%154.70M

35.05%147.61M

41.57%145.69M

0.13%109.40M

-17.53%122.23M

5.33%109.30M

总权益

26.59%436.18M

-27.64%278.88M

-30.71%292.54M

-32.00%315.33M

-33.10%344.56M

-16.47%385.39M

-17.58%422.18M

-20.47%463.75M

-17.32%515.04M

-22.10%461.37M

-23.19%512.23M

-21.20%583.10M

-22.33%622.91M

-30.75%592.26M

-27.23%666.88M

-23.71%739.96M

-21.67%801.95M

-20.06%855.23M

-15.12%916.41M

-13.30%969.94M

现金流量表

经营净额

18.02%-32.00M

75.60%-12.91M

24.79%-27.60M

32.70%-29.69M

38.62%-39.03M

5.31%-52.93M

31.67%-36.70M

20.56%-44.12M

-2.80%-63.59M

16.12%-55.90M

13.51%-53.71M

-16.53%-55.53M

-45.44%-61.86M

2.34%-66.64M

-36.67%-62.10M

2.50%-47.66M

-3.31%-42.53M

-38.33%-68.24M

-355.50%-45.44M

-30.04%-48.88M

投资净额

-436.62%-147.56M

-579.08%-29.59M

-38.81%33.61M

115.71%11.94M

-41.25%43.84M

-72.10%6.18M

-18.57%54.93M

-121.76%-75.99M

334.81%74.61M

-80.40%22.13M

36.02%67.46M

-237.59%-34.27M

-68.24%17.16M

604.69%112.94M

69.56%49.60M

91.39%24.91M

119.70%54.03M

-123.12%-22.38M

31.70%29.25M

115.61%13.01M

融资净额

3604.10%187.87M

50.98%21.12M

36.84%7.86M

376.58%3.24M

-95.33%5.07M

747.88%13.99M

3605.16%5.74M

-84.15%679.00K

21.31%108.60M

-4.68%1.65M

236.96%155.00K

301.97%4.29M

372916.67%89.52M

-4.58%1.73M

-85.71%46.00K

-55.27%1.07M

-99.25%24.00K

-69.99%1.81M

-97.52%322.00K

-38.14%2.38M

常见问题

Allogene Therapeutics Inc的流动资产是多少？



根据Allogene Therapeutics Inc的FY2025财报，流动资产为257.75M（同比变化-15.04）。

Allogene Therapeutics Inc的总资产是多少？



根据Allogene Therapeutics Inc的FY2025财报，Allogene Therapeutics Inc的总资产为415.90M（同比变化-24.20）。

Allogene Therapeutics Inc的总负债是多少？



根据Allogene Therapeutics Inc的FY2025财报，Allogene Therapeutics Inc的总负债为123.36M（同比变化-2.50）。

Allogene Therapeutics Inc的总权益是多少？



根据Allogene Therapeutics Inc的FY2025财报，Allogene Therapeutics Inc的总权益为292.54M（同比变化-30.71）。

Allogene Therapeutics Inc的净营业收入是多少？



根据Allogene Therapeutics Inc的FY2025财报，Allogene Therapeutics Inc的净营业收入为-206.93M（同比变化19.63）。

Allogene Therapeutics Inc的净投资是多少？



根据Allogene Therapeutics Inc的FY2025财报，Allogene Therapeutics Inc的净投资为95.56M（同比变化26.25）。

Allogene Therapeutics Inc的净融资是多少？



根据Allogene Therapeutics Inc的FY2025财报，Allogene Therapeutics Inc的净融资为30.16M（同比变化-74.15）。

Allogene Therapeutics Inc的每股收益（EPS）是多少？



根据Allogene Therapeutics Inc的FY2025财报，每股收益（EPS）为-0.87（同比变化34.57）。

Allogene Therapeutics Inc的净利润是多少？



根据Allogene Therapeutics Inc的FY2025财报，净利润为-190.89M（同比变化25.90）。

Allogene Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Allogene Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-53.42（同比变化3.12）。

Allogene Therapeutics Inc的资产回报率（ROA）是多少？



根据Allogene Therapeutics Inc的FY2025财报，资产回报率（ROA）为-39.58（同比变化8.46）。

Allogene Therapeutics Inc的营业利润是多少？



根据Allogene Therapeutics Inc的FY2025财报，营业利润为-206.93M（同比变化19.63）。